Table 2.
Detailed information of the detected molecules.a
| Indicators | HCs | Stroke | PSD | p value (HCs vs. Stroke) | p value (HCs vs. PSD) | p value (PSD vs. Stroke) | Rb |
|---|---|---|---|---|---|---|---|
| iFABP (pg/ml) | 4887.13 | 5045.08 | 5733.85 | 0.98 | 1.67E-06 | 1.09E-04 | 0.74 |
| sCD14 (ng/ml) | 464.68 | 413.56 | 422.08 | 0.13 | 0.28 | 0.99 | 0.06 |
| LBP (μmol/L) | 290.16 | 254.88 | 268.59 | 0.26 | 0.87 | 0.99 | 0.15 |
| CRP (mg/L) | 3.66 | 7.57 | 15.12 | 0.33 | 0.06 | 0.41 | 0.19 |
| Lp(a) (mg/L) | 244.08 | 249.71 | 475.17 | 0.99 | 0.001 | 0.003 | 0.78 |
| ApoB (g/L) | 0.95 | 0.94 | 0.82 | 0.98 | 0.028 | 0.038 | 0.06 |
| FFA (μmol/L) | 444.88 | 604.65 | 522.35 | 0.002 | 0.15 | 0.29 | -0.44 |
| TC (mmol/L) | 5.15 | 4.72 | 3.75 | 0.069 | 7.79E-12 | 3.94E-05 | -0.2 |
| Apo A1 (g/L) | 1.47 | 1.36 | 1.09 | 0.042 | 3.06E-12 | 4.36E-10 | -0.96 |
| HDL-C (mmol/L) | 1.49 | 1.36 | 1.13 | 0.019 | 2.69E-09 | 1.40E-04 | -0.43 |
| LDL-C (mmol/L) | 2.99 | 2.6 | 2.07 | 0.069 | 8.16E-07 | 0.007 | -0.03 |
| TG (mmol/L) | 1.45 | 1.3 | 1.41 | 0.802 | 0.99 | 0.99 | 0.25 |
| HDL/LDL | 0.52 | 0.57 | 0.6 | 0.686 | 0.182 | 0.99 | -0.31 |
| ApoE (mg/L) | 31.69 | 38 | 36.46 | 0.068 | 0.251 | 0.99 | 0.15 |
| Glucose (mmol/L) | 6.19 | 6.43 | 5.85 | 0.927 | 0.623 | 0.384 | -0.22 |
| Creatinine (μmol/L) | 69.44 | 70.67 | 70.13 | 0.984 | 0.99 | 0.99 | -0.28 |
iFABP, intestinal fatty acid binding protein; sCD14, soluble cluster of differentiation 14; LBP, lipopolysaccharide binding protein; CRP, high-sensitivity C-reactive protein; Lp(a), lipoprotein (a); ApoB, apolipoprotein B; FFA, free fatty acid; TC, total cholesterol; Apo A1, apolipoprotein A1; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; TG, triglyceride; ApoE, apolipoprotein E.
a
one-way ANOVA or chi-square test was used to obtain p-values.
b
correlation coefficient from OPLS loading coefficient plots resulted.